22 Aug 2017 | 12:42 PM
 

Bafna Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532989 | NSE Symbol: BAFNAPHARM
23.00
0.10
(0.44 %)
22 Aug 2017 | 12:24 PM
Change company
  • Open (Rs)
    22.05
  • Prev. close (Rs.)
    22.90
  • High (Rs.)
    23.00
  • Low (Rs.)
    22.05
  • 52W H (Rs.)
    35.80
  • 52W L (Rs.)
    20.00
  • Volume (Rs.)
    3780
  • MCap (Rs in Cr.)
    42.91
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-7.52
Operating Margin (%)
0.60
Gross Profit Margin (%)
-5.08
Net Profit Margin (%)
-16.44
Total Debt/Equity
1.39
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

08 Aug 2017 - 19:55:00-The company reported standalone net loss during the quarter stood at Rs 7...
10 Jun 2015 - 11:12:00-Drug maker Bafna Pharmaceuticals Ltd on Wednesday said it has received the renewal certificate from ...
28 Oct 2014 - 11:15:00-Bafna Pharmaceuticals today said that it has appointed RS Gowdhaman as Company Secretary & Complianc...
26 Nov 2013 - 09:51:00-Shares of drug maker Bafna Pharmaceuticals rallied over 19 per cent in early trade on Bombay Stock E...

Announcements

14-Aug-2017
Bafna Pharmaceutical - Reply to Clarification- Financial results
10-Aug-2017
Bafna Pharmaceutical - Reply to Clarification Sought
09-Aug-2017
Bafna Pharmaceutical - Clarification
09-Aug-2017
Bafna Pharmaceutical - Clarification - Financial Results
21-Jul-2017
Bafna Pharmaceutical - Financial Results For 31St March 2017.

Religare Research

21 Aug 2017 | 07:14 PM
Gold prices retreated on Friday after surging to their highest level in nine months earlier on the b...
21 Aug 2017 | 05:45 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
21 Aug 2017 | 10:07 AM
The Indian rupee ended little changed after across-the-board dollar sales by banks, likely for their...
21 Aug 2017 | 09:25 AM
• Gold surges over nine months high to $1,300 • Oil reversed and jumped more than 2 percent • Zinc ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors33.42%
Mutual Funds/UTI0.00%
FI/Banks0.25%
Insurance0.25%
FII0.00%
Government0.00%
Others15.95%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,264.65(-1.12)
3578
 Kovai Medical Center and Hospital Ltd.
1,244.95(1.06)
11816
 Merck Ltd.
1,154.40(0.36)
3302
 Coral Laboratories Ltd.
928.00(-1.37)
3462

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bafna Pharmaceuticals Ltd.-5.80-4.50-8.70
NIFTY(S&P CNX)-121.00356.00886.40
BSE SENSEX-661.41796.512,605.89
BSE 500-202.63485.121,295.07

Corporate Details

Key Personal
B Kamlesh Kumar
Ind. Non-Executive Director
Bafna Mahaveer Chand
Chairman & Managing Director
K Sabitha
Non Ind.& Exe.Director
Key Address
Registered Office
Bafna Towers New?No.?68 ?Old?No. 299 ?? ? Thambu Chetty Street,Chennai (Madras),Tamil Nadu

Tel:044-25267517 42677555 25270992, Fax:044-25231264 42677599 25270

info@bafnapharma.com
http://www.bafnapharma.com
Registrar Office
Cameo Corporate Services Ltd.
Add. :Subramanian Building No.1 Vth Floor Club House Road

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Bafna Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Bafna Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Bafna Pharmaceuticals Ltd.